Ginwa Enterprise Group (SHSE:600080) ROCE %: 1.10% (As of Mar. 2026)


SHSE:600080 Ginwa Enterprise Group Inc SHSE:600080
47 GF Score
Price ¥4.94
GF Value ¥7.53
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Ginwa Enterprise Group ROCE %?

Ginwa Enterprise Group SHSE:600080 -1.20% 47 ROCE % is 1.10% as of Mar. 2026. GuruFocus rates SHSE:600080 with a GF Score™ of 47/100 and a GF Value™ of ¥7.53 (Possible Value Trap). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ginwa Enterprise Group's annualized ROCE % for the quarter that ended in Mar. 2026 was 1.10%.

Ginwa Enterprise Group  (SHSE:600080) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ginwa Enterprise Group ROCE % Related Terms

Ginwa Enterprise Group ROCE % Historical Data

* Premium members only.

The historical data trend for Ginwa Enterprise Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ginwa Enterprise Group ROCE % Chart

Ginwa Enterprise Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.25 2.87 -2.18 2.84 1.46

Ginwa Enterprise Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 1.20 8.09 -3.94 1.10
SHSE:600080
47GF Score
Ginwa Enterprise Group Inc SHSE:600080
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ginwa Enterprise Group ROCE % Calculation

Ginwa Enterprise Group's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=23.374/( ( (1972.071 - 367.094) + (1927.96 - 326.47) )/ 2 )
=23.374/( (1604.977+1601.49)/ 2 )
=23.374/1603.2335
=1.46 %

Ginwa Enterprise Group's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=17.88/( ( (1927.96 - 326.47) + (1962.874 - 300.719) )/ 2 )
=17.88/( ( 1601.49 + 1662.155 )/ 2 )
=17.88/1631.8225
=1.10 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 1.10% mean?
Ginwa Enterprise Group (SHSE:600080) has a ROCE % of 1.10% as of Mar. 2026.
Is Ginwa Enterprise Group's ROCE % too high?
Ginwa Enterprise Group's current ROCE % is 1.10%. The Drug Manufacturers industry median ROCE % is 7.03. Ginwa Enterprise Group's value of 1.10% is 84.4% below this industry median. Overall, Ginwa Enterprise Group has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ginwa Enterprise Group's ROCE % compare to ZTS and UTHR?
Ginwa Enterprise Group's ROCE % of 1.10% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. Ginwa Enterprise Group's value of 1.10% is 84.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ginwa Enterprise Group's current ROCE % of 1.10% is 84.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ginwa Enterprise Group's current ROCE % is 1.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginwa Enterprise Group stock overvalued right now?
Based on GuruFocus' analysis, Ginwa Enterprise Group (SHSE:600080) is currently considered Possible Value Trap. The stock's GF Value™ is ¥7.53, compared to a current price of ¥4.94 — trading 34.4% below its estimated fair value. The current ROCE % is 1.10% and 84.4% below the Drug Manufacturers industry median of 7.03. Ginwa Enterprise Group's overall GF Score™ is 47/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Ginwa Enterprise Group (SHSE:600080), the current ROCE % is 1.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ginwa Enterprise Group (SHSE:600080) Overvalued in 2026?

Based on GuruFocus' analysis, Ginwa Enterprise Group stock appears to be undervalued. The current stock price of ¥4.94 is trading 34.4% below its estimated GF Value™ of ¥7.53. GuruFocus considers Ginwa Enterprise Group to be Possible Value Trap.

Key valuation signals for SHSE:600080:

  • ROCE %: 1.10%
  • GF Value™: ¥7.53 vs. price of ¥4.94 (34.4% below fair value)
  • GF Score™: 47/100 with 2 warning signs
  • Industry Position: 84.4% below the Drug Manufacturers median

No single metric tells the full story. See the SHSE:600080 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ginwa Enterprise Group Business Description

Address Gaoxin 3rd Road, 40th Floor, South Tower, Phase III, Fortune Center, Gaoxin District, Xi'an, CHN, 710075
Ginwa Enterprise Group Inc operates in the pharmaceutical industry. The main business is the research and development, production, and sales of drugs, and the product line covers chemical drugs, Chinese patent medicines, raw materials, and health products. The dosage forms include tablets, capsules, granules, powders, mixtures, oral solutions, syrups, external solutions, and more than 100 varieties and specifications.
47GF Score

Get the complete analysis for SHSE:600080

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.94
Price
¥7.53
GF Value